We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+15.7%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$550M
AUM Growth
+$193M
Cap. Flow
+$66.2M
Cap. Flow %
12.03%
Top 10 Hldgs %
37.74%
Holding
95
New
27
Increased
22
Reduced
33
Closed
9

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$20.4M
2
NEE icon
NextEra Energy
NEE
+$17.3M
3
ADBE icon
Adobe
ADBE
+$16.2M
4
LITE icon
Lumentum
LITE
+$11.7M
5
FISV
Fiserv Inc
FISV
+$11M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 19.78%
3 Financials 11.08%
4 Industrials 10.58%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
51
Procter & Gamble
PG
$343B
$1.77M 0.32%
12,738
+810
+7% +$108K
BMY icon
52
Bristol-Myers Squibb
BMY
$127B
$1.67M 0.3%
+27,750
New +$1.67M
BCE icon
53
BCE
BCE
$19.9B
$1.66M 0.3%
+40,000
New +$1.69M
JPM icon
54
JPMorgan Chase
JPM
$939B
$1.65M 0.3%
+17,100
New +$1.68M
CAH icon
55
Cardinal Health
CAH
$53.4B
$1.62M 0.29%
+34,500
New +$1.77M
CSCO icon
56
Cisco
CSCO
$450B
$1.35M 0.25%
+34,327
New +$1.5M
SNY icon
57
Sanofi
SNY
$104B
$1.33M 0.24%
+26,500
New +$1.36M
AWK icon
58
American Water Works
AWK
$26.3B
$1.3M 0.24%
8,950
+100
+1% +$14.2K
NBIX icon
59
Neurocrine Biosciences
NBIX
$17.7B
$1.14M 0.21%
11,883
+133
+1% +$15.4K
STE icon
60
Steris
STE
$20.9B
$951K 0.17%
5,400
-50
-0.9% -$8K
HSIC icon
61
Henry Schein
HSIC
$9.74B
$895K 0.16%
15,230
-400
-3% -$25.7K
ATO icon
62
Atmos Energy
ATO
$29.9B
$842K 0.15%
8,810
+200
+2% +$20K
IART icon
63
Integra LifeSciences
IART
$1.54B
$690K 0.13%
14,608
+210
+1% +$9.99K
WASH icon
64
Washington Trust Bancorp
WASH
$732M
$654K 0.12%
21,347
-694
-3% -$22.9K
ADP icon
65
Automatic Data Processing
ADP
$100B
$600K 0.11%
4,300
-45,300
-91% -$6.35M
BRK.B icon
66
Berkshire Hathaway Class B
BRK.B
$1.07T
$596K 0.11%
2,800
-500
-15% -$102K
GILD icon
67
Gilead Sciences
GILD
$161B
$576K 0.1%
9,115
-100
-1% -$6.93K
BLD
68
DELISTED
TopBuild
BLD
$550K 0.1%
3,221
+7
+0.2% +$1K
ECL icon
69
Ecolab
ECL
$75.6B
$540K 0.1%
2,700
-50
-2% -$9.99K
QRVO icon
70
Qorvo
QRVO
$7.63B
$488K 0.09%
3,783
UNP icon
71
Union Pacific
UNP
$183B
$465K 0.08%
2,364
-100
-4% -$18.6K
CI icon
72
Cigna
CI
$76.6B
$460K 0.08%
2,715
-24
-0.9% -$4.22K
RGA icon
73
Reinsurance Group of America
RGA
$15.7B
$457K 0.08%
4,800
-200
-4% -$18K
NEE icon
74
NextEra Energy
NEE
$187B
$333K 0.06%
4,800
-251,200
-98% -$17.3M
SRCL
75
DELISTED
Stericycle Inc
SRCL
$325K 0.06%
5,151

Similar funds

De Burlo Group's Q3 2020 Portfolio in Review

As of Q3 2020, De Burlo Group held 95 positions worth $550M, up 54% from $357M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

De Burlo Group deployed $66.2M of net new capital in Q3 2020, opening 27 new positions and adding to 22 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $20.4M trimmed.

  • De Burlo Group's largest Q3 2020 buy was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.
  • De Burlo Group added most to Church & Dwight Co in Q3 2020, an estimated $17.8M increase.
  • De Burlo Group's biggest Q3 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $20.4M.
  • De Burlo Group fully exited Lumentum in Q3 2020, selling an estimated $11.7M.
  • De Burlo Group's ten largest holdings make up 38% of its $550M portfolio in Q3 2020.
  • De Burlo Group opened 27 new positions and closed 9 in Q3 2020.
  • De Burlo Group's portfolio value rose 54% quarter-over-quarter to $550M.

Based on De Burlo Group's 13F filing for Q3 2020, filed 5 Nov 2020.